Single agent gemcitabine (gem) in metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Hugec, V [1 ]
Koulova, L [1 ]
Garino, A [1 ]
Wiernik, PH [1 ]
Dutcher, JP [1 ]
机构：
[1] Our Lady Mercy Med Ctr, Bronx, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：452S / 452S
页数：1
相关论文
共 50 条
  • [31] Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
    Gupta, Kiran
    Miller, Jeffrey D.
    Li, Jim Z.
    Russel, Mason W.
    Charbonneau, Claudie
    CANCER TREATMENT REVIEWS, 2008, 34 (03) : 193 - 205
  • [32] Pharmacokinetics (PK) and efficacy of sunitinib in patients with metastatic renal cell carcinoma (mRCC).
    Houk, B. E.
    Amantea, M.
    Motzer, R. J.
    Michaelson, M. D.
    Rini, B. I.
    George, D. J.
    Redman, B. G.
    Hudes, G. R.
    Poland, B.
    Bello, C. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 224S - 224S
  • [33] Antibiotic use and outcomes with systemic therapy in metastatic renal cell carcinoma (mRCC).
    Lalani, Aly-Khan A.
    Xie, Wanling
    Lin, Xun
    Steinharter, John A.
    Martini, Dylan J.
    Duquette, Audrey
    Bosse, Dominick
    McKay, Rana R.
    Simantov, Ronit
    Wei, Xiao X.
    McGregor, Bradley A.
    Harshman, Lauren Christine
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [34] Metastatic Renal Cell Carcinoma (mRCC) Clinical Evidence and Quality of Supply in Germany
    Krause, Andreas
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (12) : 795 - 795
  • [35] Sunitinib in patients with cytokine-refiractory metastatic renal cell carcinoma (mRCC)
    George, D. J.
    Michaelson, M. D.
    Rosenberg, J. E.
    Redman, B. G.
    Hudes, G. R.
    Bukowski, R. M.
    Kim, S. T.
    Chen, I.
    Wilding, G.
    Motzer, R. J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 304 - 304
  • [36] SAFETY PROFILE OF SUNITINIB AND SORAFENIB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)
    Massari, Francesco
    Sperandi, Francesca
    Cricca, Antonia
    Melotti, Barbara
    Martoni, Andrea Angelo
    ANNALS OF ONCOLOGY, 2009, 20
  • [37] CARDIOTOXICITY IN METASTATIC RENAL CELL CARCINOMA (mRCC) PATIENTS TREATED WITH SUNITINIB (SU)
    Ballatore, Valentina
    Prati, Veronica
    Ruatta, Fiorella
    Galizia, Danilo
    Grignani, Giovanni
    Aglietta, Massimo
    Ortega, Cinzia
    ANTICANCER RESEARCH, 2012, 32 (05) : 1876 - 1877
  • [38] Epidemiologic, humanistic and economic burden of patients with metastatic renal cell carcinoma (MRCC)
    Banks, J.
    Gupta, K.
    Balu, S.
    Chen, E.
    Komatsuzaki, Y.
    Charbonneau, C.
    Pashos, C. L.
    VALUE IN HEALTH, 2006, 9 (06) : A276 - A276
  • [39] Body composition parameter as risk predictor in metastatic renal cell carcinoma (mRCC)?
    Heetfeld, Constantin
    Hensen, Bennet
    Eggers, Hendik
    Peters, Inga
    Kuczyk, Markus A.
    Gruenwald, Viktor
    Ivanyi, Philipp
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16506 - E16506
  • [40] Disparities in the receipt of palliative care (PC) in metastatic renal cell carcinoma (mRCC).
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Tandra, Pavan Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345